4 March 2020

Preclinical study shows how commonly prescribed drugs for Alzheimer’s disease interfere with the activity of the tau aggregation inhibitor hydromethylthionine

Conceptual illustration of neuron cells with glowing link knots in abstract dark space, high resolution 3D illustration

ABERDEEN, Scotland and Singapore, 04 March, 2020 – Today, TauRx Therapeutics announced the publication of a study in an Alzheimer’s disease (AD) mouse model which demonstrates that drugs currently used to manage the symptoms of the disease interfere with the activity of a drug with an entirely unrelated mode of action.

The preclinical research, published online in Current Alzheimer Research1 (abstract available here; manuscript available here), showed that prior treatment with rivastigmine (an acetylcholinesterase inhibitor) negatively affected the pharmacological activity of hydromethylthionine which acts on the tau aggregation pathology of AD.

Read more here.

Press Release Preclinical study March 2020

Today, TauRx Therapeutics announced the publication of a study in an Alzheimer’s disease (AD) mouse model

More news

MHRA confirms acceptance of UK Marketing Authorisation Application for HMTM

TauRx submits UK marketing authorisation application for HMTM as a treatment for Alzheimer’s disease

Doctor examining MRI, MRT, CT scan image of human brain. Medical treatment concept. Diagnosis of the disease humans head. Close up.

Two year sustained cognitive benefits of Hydromethylthionine Mesylate (HMTM) indicated by TauRx’s LUCIDITY trial

Further reading

For decades, Professor Claude Wischik, co-founder and CEO of TauRx, has led a scientific research team dedicated to finding an effective treatment for neurodegenerative diseases.

Doctor or nurse caregiver with senior couple at home or nursing home

Clinical trials

TauRx recently completed its latest Phase III clinical trials in Alzheimer’s disease and in the rare neurodegenerative disorder, behavioural variant frontotemporal dementia (bvFTD).

Gears. Cog mechanism, engine system, operation progress, gear shift, industry innovation, engineering solution, technology concept.

Environmental, Social and Governance at TauRx

Maintaining integrity, accountability and transparency in our pursuit of life-changing treatments